Abstract:Object: To construct,express,purify anti-VEGF antibody Fab fragment in E. coli,and to assay its activity. Through controlling the fermentation conditions,Fab fragment can be achieved actively and largely by secreting to the periplasmic space or extracellular medium. Methods: The co-expression plasmid pET30a-LC-HC which has the OmpA signal peptide,SD sequence and the T7 promoter before Fd chain and L chain was successfully constructed. Then the plasmid was transformed into Escherichia coil BL21( DE3). The inducing condition including medium,temperature and IPTG concentration was also optimized. Results: The best shaking fermentation condition on Escherichia coil periplasmic secretory expression: in 1L XY1 medium that including 1.5% Tryptone,1% Yeast Extract,0. 5% Glucose,0. 15% NaCl,0. 1% NH4 Cl,0. 08% MgCl2~ 6H2 O,the strains were cultured with 10% inoculum at 37℃,and then added 0. 1mM IPTG until the late logarithmic growth phase( OD600 was about 2) to induced overnight( about 16h) at 16 ℃. Except periplasmic expression,there is also a considerable part of Fab that secrete into the medium. Fab fragment which secrected into the periplasm was extracted by breaking periplasm of bacteria. At the same time,the culture medium were concentrated with the hollow fiber column,and further purified Fab by ProteinG affinity chromatography. At last,we got the purified Fab antibody fragments with more than 90% purity by SDS-PAGE analysis. The protein concentration is measured with Brandford detection method. The amount of purified Fab from periplasm and medium is up to 0. 4mg /L. Taking the VEGF165 as the binding antigen,the half-maximal effective concentration( EC50) of the purified Fab is30 ng /ml being analyzed indirectly by ELISA,which show a high antigen-binding activity. Then 3. 7L fermentor with 2L volume of XY1 culture mediun is used to do small pilot scale fermentation. The final cell yield is 30 g /L in the 3. 7L fermenter with 2L culture medium,and the concentration of Fab antibody purified by affinity column is1. 94 mg /L. Conclusion: Fab fragment can be successful and high-efficiently secrected into the periplasmic space and extracellular medium through constructing the co-expression vector and optimizing the fermentation condition,and has highly activity against VEGF. It provides research basis for large-scale preparation of Fab antibody fragment.

Expression and functional reconstitution of a recombinant antibody (Fab′) specific for human apolipoprotein B-100

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

Prokaryotic Expression and Renaturation of Engineering Chimeric Fab Antibody Against Human Hepatoma.

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

A General Platform for Efficient Extracellular Expression and Purification of Fab from Escherichia Coli.

Recombinant Functional Human Lactoferrin Expressed in Baculovirus System

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Construction and Expression of a Human/mouse Chimeric CD19 Monoclonal Antibody: Successful Modification of a Murine IgM to a Chimeric IgG.

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Construction of prokaryotic expression vector of recombinant human apolipoprotein A5 and its analysis and identification

Design of an alternate antibody fragment format that can be produced in the cytoplasm of Escherichia coli

The Secretory Expression of an Anti-VEGF Antibody Fab Fragment in E.coli

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive

Recovery of IgG binding capability of human FcγRⅡa refolded by rapid dilution expressed in E. coli

Efficient Recovery of A Functional Extracellular Domain of Bovine Igg2 Fc Receptor (bofc Gamma 2r) from Inclusion Bodies by A Rapid Dilution Refolding System

Expression and purification of a secreted functional mouse/human chimaeric antibody against bacterial endotoxin in baculovirus‐infected insect cells

Foam fractionation studies of recombinant human apolipoprotein A-I

Efficient Antibody Assembly in E. coli Periplasm by Disulfide Bond Folding Factor Co-expression and Culture Optimization

Synthesis and characterization of a functional intact IgG in a prokaryotic cell-free expression system

[Over-Expression in Escherichia Coli and Characterization of Apolipoprotein AI].